Bio-AMD Inc  

(Public, OTCMKTS:BIAD)   Watch this stock  
Find more results for OTC:BIAD
-0.0150 (-14.29%)
Nov 25 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.09 - 0.10
52 week 0.02 - 0.30
Open 0.10
Vol / Avg. 7,355.00/30,524.00
Mkt cap 4.14M
P/E     -
Div/yield     -
EPS -0.02
Shares 45.98M
Beta -2.86
Inst. own 0%

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -83.55% -77.29%
Return on average equity -79.38% -39.04%
Employees 2 -
CDP Score - -


3rd Floor, 14 South Molton Street
United Kingdom - Map
+44-844-5862780 (Phone)

Website links


Bio-Amd, Inc. is engaged in developing its Point Of Care (POC) medical diagnostic device business; and commercializing its WOCU-based currency risk mitigation business. The Company operates through two segments: the development of a technology designed to mitigate currency risk through its 99.81% owned subsidiary, WOCU Limited (WL), and the development of hand held, electronic medical diagnostic devices capable of reading third party assays through its 63% owned subsidiary, Bio-AMD Holdings Limited. The Company offers a disposable micro-fluidic test strip, which has been adapted to measure prothrombin time (PT/INR) through a POC blood coagulation monitoring device (COAG); a Digital Strip Reader (DSR) to read a range of lateral flow-based immunoassay diagnostic test strips already in the POC market, and a disposable test strip combining micro-fluidics and lab-on-chip technology.

Officers and directors

David S. Miller President, Secretary, Director
Age: 54
Thomas Barr Chief Executive Officer, Director
Age: 55
Robert Galvin Chief Financial Officer, Treasurer, Director
Age: 45